Greg A. Miller

873 total citations
39 papers, 684 citations indexed

About

Greg A. Miller is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Greg A. Miller has authored 39 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Greg A. Miller's work include Endometrial and Cervical Cancer Treatments (8 papers), Cancer-related Molecular Pathways (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Greg A. Miller is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Cancer-related Molecular Pathways (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Greg A. Miller collaborates with scholars based in United States, Australia and Singapore. Greg A. Miller's co-authors include John P. Geisler, Michael C. Wiemann, Hans E. Geisler, William Crabtree, Takeshi Hirose, B. W. Scheithauer, Fredric B. Meyer, Richard A. Sidner, Oscar W. Cummings and Howard Thomas and has published in prestigious journals such as Cancer, The Journal of Urology and The American Journal of Surgical Pathology.

In The Last Decade

Greg A. Miller

38 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg A. Miller United States 13 208 180 171 162 157 39 684
Choutatsu Tsukayama Japan 15 319 1.5× 203 1.1× 310 1.8× 149 0.9× 139 0.9× 24 801
Pascasio Aguirre United States 11 110 0.5× 225 1.3× 243 1.4× 166 1.0× 279 1.8× 12 668
H Pickartz Germany 12 181 0.9× 193 1.1× 56 0.3× 149 0.9× 224 1.4× 39 805
Eva Cristóbal Spain 15 276 1.3× 66 0.4× 65 0.4× 122 0.8× 128 0.8× 29 715
Ross Barner United States 12 143 0.7× 112 0.6× 76 0.4× 156 1.0× 247 1.6× 14 554
Almudena Santón Spain 17 356 1.7× 98 0.5× 66 0.4× 171 1.1× 113 0.7× 43 861
André Pinto United States 16 270 1.3× 175 1.0× 82 0.5× 157 1.0× 119 0.8× 56 753
Kyaw Aung Canada 11 534 2.6× 78 0.4× 146 0.9× 129 0.8× 146 0.9× 21 806
Kiyong Na South Korea 18 157 0.8× 199 1.1× 83 0.5× 175 1.1× 260 1.7× 66 835
Farnaz Dadmanesh United States 13 197 0.9× 147 0.8× 44 0.3× 100 0.6× 133 0.8× 33 634

Countries citing papers authored by Greg A. Miller

Since Specialization
Citations

This map shows the geographic impact of Greg A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg A. Miller more than expected).

Fields of papers citing papers by Greg A. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg A. Miller. The network helps show where Greg A. Miller may publish in the future.

Co-authorship network of co-authors of Greg A. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Greg A. Miller. A scholar is included among the top collaborators of Greg A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg A. Miller. Greg A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loh, Amos Hong Pheng, Elizabeth Stewart, Cori Bradley, et al.. (2018). Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations. Cancer Letters. 442. 262–270. 21 indexed citations
2.
Geisler, John P., et al.. (2007). Vascular endothelial growth factor staining and elevated INR in advanced epithelial ovarian carcinoma. Journal of Surgical Oncology. 96(6). 514–517. 3 indexed citations
3.
Miller, John W., John P. Geisler, Kelly J. Manahan, et al.. (2004). Nuclear size, shape, and density in endometrial carcinoma: relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G0-G1 peak add useful information?. International Journal of Gynecological Cancer. 14(1). 138–144. 6 indexed citations
4.
Geisler, John P., Hans E. Geisler, Kelly J. Manahan, et al.. (2004). Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival. International Journal of Gynecological Cancer. 14(1). 133–137. 30 indexed citations
5.
Sidner, Richard A., Greg A. Miller, Oscar W. Cummings, et al.. (2003). Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. The American Journal of Surgery. 186(5). 486–492. 55 indexed citations
6.
Geisler, Hans E., et al.. (2001). p21 and p53 in ovarian carcinoma. Cancer. 92(4). 781–786. 34 indexed citations
7.
Geisler, John P., et al.. (2000). p53 and bcl-2 in Epithelial Ovarian Carcinoma: Their Value as Prognostic Indicators at a Median Follow-up of 60 Months. Gynecologic Oncology. 77(2). 278–282. 48 indexed citations
8.
Geisler, John P., et al.. (1999). p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer. Gynecologic Oncology. 74(3). 468–471. 56 indexed citations
9.
Geisler, John P., et al.. (1999). Markov optical texture parameters as prognostic indicators in ovarian carcinoma. International Journal of Gynecological Cancer. 9(4). 317–321. 8 indexed citations
10.
Sidner, R.A., Greg A. Miller, & Rahul M. Jindal. (1998). Effects of Coculture on Viability of Rat Pancreatic Islets. Transplantation Proceedings. 30(2). 377–378. 1 indexed citations
11.
Geisler, John P., et al.. (1997). Quantification of p53 in Epithelial Ovarian Cancer. Gynecologic Oncology. 66(3). 435–438. 40 indexed citations
12.
Geisler, John P., et al.. (1996). p53 as a Prognostic Indicator in Endometrial Cancer. Gynecologic Oncology. 61(2). 245–248. 39 indexed citations
13.
Albers, Peter, Thomas M. Ulbright, Greg A. Miller, et al.. (1996). Tumor Proliferative Activity is Predictive of Pathological Stage in Clinical Stage a Nonseminomatous Testicular Germ Cell Tumors. The Journal of Urology. 155(2). 579–586. 35 indexed citations
14.
Geisler, John P., et al.. (1996). DNA index by image analysis in advanced endometrial carcinoma. Journal of Surgical Oncology. 63(2). 91–94. 5 indexed citations
15.
Geisler, John P., et al.. (1995). Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary. Journal of Surgical Oncology. 59(1). 45–47. 17 indexed citations
16.
17.
Engum, Scott A., R.A. Sidner, Greg A. Miller, & Jay L. Grosfeld. (1994). Does preoperative chemotherapy for hepatic tumors have an adverse effect on hepatic proliferation after delayed liver resection?. Journal of Pediatric Surgery. 29(8). 1090–1094. 5 indexed citations
18.
Engum, Scott A., R.A. Sidner, Greg A. Miller, Carlos Galliani, & Jay L. Grosfeld. (1993). Early use of cisplatin is safe after partial hepatectomy. Journal of Pediatric Surgery. 28(3). 411–419. 6 indexed citations
19.
Miller, Greg A., et al.. (1991). PRIMARY CARCINOID TUMOUR OF THE ILEUM ASSOCIATED WITH MASSIVE GASTROINTESTINAL HAEMORRHAGE. Australian and New Zealand Journal of Surgery. 61(8). 645–646. 6 indexed citations
20.
Miller, Greg A. & M Savary. (1977). [Is gastro-esophageal prolapse responsible for lesions of the gastric mucosa? (proceedings)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(1). 42–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Choutatsu Tsukayama Breakdown of academic impact, for papers by Pascasio Aguirre Breakdown of academic impact, for papers by H Pickartz Breakdown of academic impact, for papers by Eva Cristóbal Breakdown of academic impact, for papers by Ross Barner Breakdown of academic impact, for papers by Almudena Santón Breakdown of academic impact, for papers by André Pinto Breakdown of academic impact, for papers by Kyaw Aung Breakdown of academic impact, for papers by Kiyong Na Breakdown of academic impact, for papers by Farnaz Dadmanesh
Rankless by CCL
2026